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A B S T R A C T
The Helping Families Programme is a psychoeducational parenting intervention that aims to improve outcomes
and engagement for parents aﬀected by clinically signiﬁcant personality diﬃculties. This is achieved by working
collaboratively with parents to explore ways in which their emotional and relational diﬃculties impact on
parenting and child functioning, and to identify meaningful and realistic goals for change. The intervention is
delivered via one-to-one sessions at weekly intervals over a period of 16 weeks. This protocol describes a two-
arm parallel RCT in which consenting parents are randomly allocated in a 1:1 ratio to either the Helping Families
Programme plus the usual services that the parent may be receiving from their mental health and/or social care
providers, or to standard care (usual services plus a brief parenting advice session). The primary clinical outcome
will be child behaviour. Secondary clinical outcomes will be child and parental mental health, parenting sa-
tisfaction, parenting behaviour and therapeutic alliance. Health economic measures will be collected on quality
of life and service use. Outcome measures will be collected at the initial assessment stage, after the intervention
is completed and at 6-month follow-up by research staﬀ blind to group allocation. Trial feasibility will be as-
sessed using rates of trial participation at the three time points and intervention uptake, attendance and re-
tention. A parallel process evaluation will use qualitative interviews to ascertain key-workers’ and parent par-
ticipants' experiences of intervention delivery and trial participation. The results of this feasibility study will
determine the appropriateness of proceeding to a full-scale trial.
1. Introduction
One in ten children in developed economies experience emotional
or behavioural diﬃculties that interfere with developmental progress,
family life and school achievement [1]. They are also at risk for poor
health and social outcomes in adolescence and adult life [2]. The
likelihood of long-term negative outcomes is increased when a parent
also has signiﬁcant personality diﬃculties for which they may or may
not have received a formal diagnosis of Personality Disorder [3]. A
substantial number of adults - around 4% in community samples and
40% in mental health services - experience persistent, pervasive and
impairing diﬃculties in managing their emotions and relationships
[4,5]. Such diﬃculties are associated with developmental trauma or
unmet needs and are often called personality disorder [6].
Persistent problems in areas of personality functioning, such as
emotional instability [7] and interpersonal hypersensitivity [8], can
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aﬀect a parent's capacity to oﬀer the stable and responsive care re-
quired for healthy child development [9]. Children of parents with
these complex interpersonal needs are more likely to require support
from child mental health and social care professionals [10]. Moreover,
having a child with emotional and/or behavioural diﬃculties can in-
crease the risk of a mental health crisis for vulnerable parents with
limited interpersonal coping resources [3].
Interventions that support parents in developing parenting skills, in
understanding the emotional needs of the child and in developing ef-
fective emotional communication lead to signiﬁcant beneﬁts in child
mental health and developmental outcomes. The strongest eﬀects are
obtained for programmes that use structured ‘psychoeducation’, in
which parents learn about child development, and the skills and ap-
plication of positive parenting and personal coping strategies [11].
Unfortunately, families aﬀected by personality diﬃculties experience
comparatively high dropout rates and worse outcomes from the typical
group format of standardised parent psychoeducation interventions
[12,13].
The ‘Helping Families Programme’ (HFP) was originally developed
for families with a range of complex needs including parental emotional
dysregulation, interpersonal hostility, early school exclusion and risk of
child maltreatment. Within this feasibility trial the HFP was adapted for
use with families aﬀected by clinically signiﬁcant personality diﬃcul-
ties. HFP uses parent-focussed cognitive, behavioural and interpersonal
strategies to optimise parents' use of positive parenting strategies and
their understanding of child development and the tasks of parenting.
This manualised approach incorporates systematic personalisation
methods to assertively engage parents who have diﬃculties often as-
sociated with personality disorder to develop intervention goals that
reﬂect the needs and preferences of individual families.
Evaluations of HFP have indicated positive parent engagement and
clinically signiﬁcant changes on a range of child and parent outcomes.
The current trial will be a test of HFP in a larger sample of families with
complex intergenerational needs, using a more rigorous randomised
controlled trial (RCT) design.
1.1. Trial aims and objectives
The aim of this study is to investigate the feasibility of undertaking a
full clinical trial of the HFP psychoeducational parenting intervention
for families aﬀected by personality diﬃculties. The speciﬁc objectives
are:
(i) To assess the feasibility of research procedures and intervention
delivery, as needed to design a full-scale trial
(ii) To investigate the inﬂuence of contextual factors on implementa-
tion and outcome generation for the intervention
(iii) To obtain variance estimates for parent and child outcomes ne-
cessary to power a full-scale trial
(iv) To measure intervention costs and make preliminary estimates of
cost-eﬀectiveness
(v) To produce a full-scale trial protocol
2. Methods
2.1. Design
A two-arm, parallel RCT will randomly allocate consenting parents
in a 1:1 ratio to: (i) the Helping Families Programme, a 16-session
psychoeducational parenting intervention, plus usual services from
mental health and/or social care providers; or (ii) standard care (usual
services plus brief parenting advice). Primary clinical outcomes will be
child and parental mental health. Secondary clinical outcomes will be
parenting satisfaction, parenting behaviour and therapeutic alliance.
Health economic measures will be collected on quality of life and ser-
vice use. Outcome measures will be collected at baseline (T1), post-
intervention (T2) and 6-month follow-up (T3) by research staﬀ blind to
group allocation. Trial feasibility will be assessed using rates of trial
participation (participant identiﬁcation, screening, eligibility, consent,
randomisation); data collection at T1, T2 and T3; and intervention
uptake, attendance and retention. A parallel process evaluation will use
observational and interview measures to understand keyworkers' and
parent participants' experiences of intervention delivery and trial par-
ticipation.
2.2. Eligibility criteria
Eligibility for the trial depends upon both parent and (index) child
meeting criteria.
Parents will (i) be the primary parental caregiver for the index child;
(ii) be aged 18–65 years; (iii) have signiﬁcant personality diﬃculties
(assessed by a score of 3 or more on the ‘Standardised Assessment of
Personality - Abbreviated Scale’ (SAPAS) [14], (iv) be proﬁcient in
written and spoken English, and (v) have capacity to provide informed
consent to participate.
The index child will be aged 3–11 years, living at home with the
index parent and have signiﬁcant emotional and/or behavioural diﬃ-
culties (score 17 or over on the ‘Strengths and Diﬃculties
Questionnaire’ Total Diﬃculties Score) [15].
Parents will be excluded if there is (i) the presence of psychosis; (ii)
they are engaged in another structured parenting intervention; (iii) they
are receiving inpatient care or (iv) they have insuﬃcient language or
cognitive abilities to participate fully in trial procedures.
Children with a pervasive developmental disorder will be excluded
from the trial, and children not residing with the index parent will also
be ineligible.
2.3. Interventions
2.3.1. Intervention arm
The Helping Families Programme (HFP) is a psychoeducational
parenting intervention that aims to improve outcomes and engagement
for families with personality diﬃculties. This is achieved by working
collaboratively with parent participants to: (i) explore the ways in
which parental emotional and relational diﬃculties impact on par-
enting and child functioning; (ii) identify meaningful and realistic goals
for change; and (iii) understand and use a range of evidence-based
parenting and self-care strategies. The intervention is delivered over 16
weekly sessions. HFP will be delivered by specially trained and su-
pervised trial therapists according to a detailed manual. This will pri-
marily involve 1:1 sessions with the primary parental caregiver, al-
though other family members may be involved when appropriate.
Parent participants will be supported to practice newly developed skills
with their child(ren) in between sessions. Sessions will take place in the
family home and/or local clinics if preferred by the parent.
HFP will be delivered in conjunction with usual services available to
participating families. A standard care coordination protocol has been
developed in concert with collaborating services, based on best practice
and local guidelines. This describes: (i) research staﬀ roles and re-
sponsibilities; (ii) coordination and continuity of care for participating
parents and their children; (iii) eﬀective management of safeguarding
concerns; and (iv) information-sharing procedures between trial
therapists and other professionals.
2.3.1.1. Control arm. Participants in the control arm will be oﬀered
standard care. This will consist of usual services, augmented by one
parent information and support session (lasting 60–90 min), derived
from an existing evidence-based parenting programme [16]. Parenting
advice will be delivered by a trained parent facilitator and will involve:
(i) supporting conversations about children's emotional and
behavioural functioning, and (ii) discussion of relevant parenting
strategies. Parents will also be provided with contact details for
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sources of additional support and information. A standard care
coordination protocol will apply, as per the intervention arm.
2.3.2. Concomitant interventions
Participants in both arms of the trial are permitted to continue with
their current medication, and to receive other interventions or treat-
ments. These will be noted using the Client Service Receipt Inventory
[17] at the follow-up stage.
2.4. Measures
2.4.1. Participant characteristics
Descriptive data from participating families will be collected about
parent and child age, sex and ethnicity, family household composition
and family socio-economic status. Basic information (professional
background, service type) about clinicians who participate in key in-
formant interviews will also be collected.
2.4.2. Feasibility outcomes
Structured record sheets will be used to document key feasibility
parameters related to trial procedures and intervention delivery.
Relevant ﬁelds will be completed prospectively by research staﬀ and
trial therapists, as appropriate. Cumulative data will be obtained on:
(i) Rates of participant identiﬁcation (initial approach by keyworker,
verbal consent for contact by research staﬀ)
(ii) Rates of trial participation (screening, eligibility, informed written
consent, randomisation), and reasons for non-participation
(iii) Rates of data collection at baseline and follow-up in both arms of
the trial, and reasons for missing data
(iv) Rates of intervention use (uptake, session attendance and reten-
tion) from participants in both arms of the trial, and reasons for
missed sessions and dropout
2.4.3. Clinical outcomes
Validated parent-report measures with well-established psycho-
metric properties will assess primary and secondary clinical outcomes.
These measures have been reviewed by service user representatives to
ensure relevance and comparative ease-of-use. The primary outcome
(child behaviour) will be measured at three time points: Time 1 (T1),
pre-randomisation baseline; Time 2 (T2), post-intervention follow-up
(approximately four months from baseline); and Time 3 (T3), 6-month
follow-up (approximately ten months from baseline). Secondary out-
comes (child internalising behaviour and parental mental health will be
assessed in parallel. Measures will be collected by researchers who are
blind to group allocation.
The primary outcome measure will be The Eyberg Child Behavior
Inventory (ECBI) [18] which is a 36-item questionnaire that assesses
intensity and number of disruptive behaviour problems in 2–16 year-
olds. It will provide a comprehensive measure of child behaviour dif-
ﬁculties.
Secondary outcomes will be child internalising behaviour, parental
concerns about the child, and parental mental health, which will be
assessed using validated parent-report questionnaires:
• The Child Behavior Checklist-Internalising Scale (CBCL-Int) [19] is a
32-item questionnaire that assesses internalising problems in 6–18
year-olds (school-age version) with an alternate 36-item version
available for children aged 1 ½ to 5 years (preschool version).
Standardised T-scores will be used to combine results from both
versions and provide a comprehensive measure of child emotional
diﬃculties.
• Concerns About My Child (CAMC) [20] is a visual analogue scale
that requires parents to nominate, prioritise and rate up to three key
concerns about their child. The same concerns that are nominated at
baseline will be re-rated at follow-up, providing a sensitive,
individualised index of change.
• The Symptom Checklist-27 (SCL-27) [21] is a 27-item questionnaire
that assesses psychological symptoms in adults. It will provide a
broad measure of parental mental health.
Other secondary outcomes measuring parenting satisfaction, par-
enting behaviour and therapeutic alliance, will also be assessed using
the following validated questionnaires:
• The Kansas Parental Satisfaction Scale (KPSS) [22] which is a 3-item
scale that provides a brief measure of stress and dissatisfaction in the
parenting role.
• The Arnold-O’Leary Parenting Scale [23] is a 30-item questionnaire
that assesses dysfunctional discipline styles in parents of children
aged from 2 to 16 years. It correlates signiﬁcantly with more time-
consuming observational ratings of parenting behaviour (r = 0.84),
and scores have been shown to diﬀerentiate between clinic and non-
referred groups of children.
• The Working Alliance Inventory-Short Revised (WAI-SR) [24] which
is a 12-item questionnaire that assesses therapeutic alliance. It will
only be completed at T2 and will be used to assess the quality of
therapeutic relationships developed by trial therapists.
2.4.4. Economic evaluations
Economic evaluation will be conducted from (i) a UK National
Health Service (NHS)/Personal Social Services perspective and (ii) a
societal perspective. Intervention costs will be estimated by combining
data on number of screening and intervention sessions provided, with
unit costs derived from local data on service expenditure and activity.
Costs will include therapist time, on-costs, overheads and capital.
Estimates of staﬀ training and supervision costs will also be included.
Other resource use information for parents and children will be col-
lected for the six months prior to baseline and follow-up using a
modiﬁed version of the Client Service Receipt Inventory (CSRI) [17].
Versions of this schedule have been used in over 300 research studies in
the UK and internationally with adults and children. Services will in-
clude primary and secondary health care, social care, school-related
services (e.g. educational psychologists and other educational support),
early years help, and youth and criminal justice services. We will also
record (i) time spent by parents accompanying their children to use
services, (ii) days oﬀ work due to health problems, and (iii) days out of
school for children. Resource use data will be combined with appro-
priate national unit costs [25] to calculate the total service costs. Par-
ental time lost from work will be valued using average wage rates. Time
lost from school is complex to value and a range of estimates will be
used in sensitivity analyses. These will include the cost of providing a
day's schooling and an estimate of the future returns from education.
For the cost-utility analysis, cost data will be combined with quality
adjusted life years (QALYs) derived from the EQ-5D [26].
2.4.5. Nested parallel process evaluation
Qualitative interviews will be conducted with key-workers and
parent participants following the follow-up assessment and interview
with the participant. Key-workers will be selected on the basis of their
involvement in recruitment and case management of participants.
Parents will be selected to ensure range and diversity in terms of trial
allocation, clinical characteristics and outcome. Interviews will be
conducted using semi-structured topic guides. These will be employed
ﬂexibly and subject to iterative development in order to reﬂect and
explore emergent themes from early interviews. Respondents will be
asked questions that explore all topics set out in the pre-deﬁned topic
list. However, the researcher will be responsive to issues emerging from
respondents' accounts. All interviews will be audio-recorded and tran-
scribed verbatim. The interview content, data collection and analytic
methods are grounded in Interpretative Phenomenological Analysis
[27] in order to gain a detailed understanding of participants' subjective
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experiences of the novel intervention and research procedures. This is
particularly important given the complex psychological needs of the
participant population.
2.5. Timeline
Individual participants will remain in the trial for approximately 11
months from the time of informed consent to the completion of research
procedures. This allows 5 months for completing baseline assessments,
randomisation and intervention delivery, followed by a 6-month period
in which further assessments are completed at T2 (immediately post-
intervention) and T3 (6 months post-intervention). The total duration
of the trial is expected to be 19 months.
2.6. Sample size
A conﬁdence interval approach [28] has been used to calculate a
sample size of N = 70 based on key feasibility objectives for the pilot
RCT. It was decided a priori that the single most important feasibility
criterion would be a treatment retention rate of at least 65%. Using a
95% CI for the proportion of parents who complete treatment and an
expected completion rate of 80% based on previous evaluations of HFP,
we have determined that a sample size of N = 35 in the intervention
arm will enable a suﬃciently precise estimate of this feasibility objec-
tive (95% CI 0.67-0.93). We expect further attrition to occur over the
subsequent follow-up period. With a sample size of N = 70 across both
groups, we can be 95% conﬁdent that the anticipated 6-month follow-
up rate of 70% will be estimated to within±10.7% points. A sample
size of N = 70 will also be suﬃcient to obtain stable estimates of po-
pulation variances for future power calculations for which at least 30
patients are recommended to estimate a parameter [29].
The process evaluation will involve qualitative interviews with
samples of parent and keyworker participants. The precise number of
participants will be determined by data saturation (and may therefore
be inﬂated), but we anticipate that this will be achieved with N = 30
informants.
2.7. Recruitment and consent procedures
Recruitment will be directed via child and adult mental health
services within the catchment area of the trial, as well as concomitant
social care agencies. Potentially eligible participants will be aﬀected by
personality diﬃculties as well as having a child with signiﬁcant emo-
tional and/or behaviour problems, and will be approached by their
usual keyworker or therapist with verbal information and a postcard-
sized leaﬂet about the research. Brieﬁngs will be provided to enable
keyworkers to accurately convey the basic aims of the research and
sensitively broach the topic of participation. Keyworkers will be
prompted to think carefully about the risks and beneﬁts that may ac-
crue from research participation, and apply professional judgment
when undertaking an exploratory discussion about the research. After
outlining what the research entails, the keyworker will determine
whether a parent is agreeable to being contacted by a researcher.
Keyworkers will then provide the research team with telephone
contact details for potential participants who have provided verbal
consent to be approached. The referring keyworker will be informed if
contact cannot be made. If contact is successful, more detailed in-
formation about the study aims, eligibility criteria and procedures will
be given verbally. Parents will also receive a Participant Information
Sheet (PIS) by post and/or email, according to their preference. They
will be encouraged to discuss the PIS with family members, keyworkers
and other professionals in their network.
Parents will be followed up by telephone, 1 week after anticipated
receipt of the PIS. If contact is successful, the researcher will seek to
address any questions about the research. The potential risks and
beneﬁts of being involved in the study will be reviewed, along with
conﬁdentiality issues, randomisation procedures and the right to
withdraw from the study at any stage. In the course of this conversa-
tion, the researcher will establish if the parent (i) is willing and able to
participate, (ii) is unwilling/unable to participate, or (iii) requires ad-
ditional time/information to make a decision. If the latter, the re-
searcher will follow up as needed. If the parent is agreeable, the re-
searcher will arrange a face-to-face meeting at a convenient time/
location to obtain informed written consent. The meeting will start with
a further review of the PIS. The researcher will explore the parent's
understanding of the research and address any outstanding questions
and concerns. If the parent is agreeable, the researcher will obtain two
signed consent forms (one for the research team; one for the participant
to keep). The researcher will then administer the two brief parent-re-
ported screening measures.
If the family is eligible, the researcher will establish if there is suf-
ﬁcient time to complete some or all of the baseline measures in the
same meeting. If needed, a separate meeting will be arranged to com-
plete measures as soon as possible. The measures, in the form of parent-
completed pen-and-paper questionnaires, will be administered in a
standard sequence and should take approximately 60–90 min to com-
plete. The researcher will be available to help with clarifying ques-
tionnaire content and instructions, and will stay alert to any signs of
discomfort that may need to be addressed sensitively and supportively.
Participants will be paid £10 per hour as reimbursement for the time
involved in data completion. This amount has been determined in ac-
cordance with good practice guidance [30,31].
2.8. Allocation and randomisation
Each participant will be allocated a unique, anonymised ID number
by the trial coordinator. Details will be entered into an independently
monitored computer system set up by the accredited Clinical Trials Unit
at King's College, London. The outcome of allocation will be commu-
nicated to the trial's senior clinical supervisor, who will then arrange for
either an HFP therapist (intervention arm) or parent facilitator (control
arm) to make contact with the allocated participant in order to com-
municate the next steps. Other members of the research team (including
the Chief Investigator, statistician and research workers) will remain
blind to participant allocation status.
Intervention delivery in both arms of the trial will begin as soon as
possible after allocation, and continue for 16 weeks. Participants will
continue to receive usual services. Care coordination will be managed
according to a standard care protocol.
2.9. Data collection
2.9.1. Screening and initial assessments
Participants will receive a text message reminder about the forth-
coming follow-up assessment, two weeks prior to the intended assess-
ment date. A researcher will then make contact by telephone one week
prior to the intended assessment date. If a participant cannot be reached
by telephone after four consecutive attempts, s/he will be sent a stan-
dard letter and asked to opt in for any further contact.
If contact is successful, the researcher will arrange a convenient
time and location to complete the measures. A reminder text message
will be sent 24 h before this scheduled assessment meeting. As with the
initial assessment, the measures will be administered in a standard se-
quence and should take approximately 60–90 min to complete. The
blinded researcher will use a standardised script during data collection
to remind participants not to disclose their allocation status.
2.9.2. First and second follow-up assessments
Researchers will maintain contact with participants, updating them
on research progress and reminding them about arrangements for
completion of T2 and T3 assessments. Each participant will also receive
a telephone call from a researcher within 1 week of the anticipated
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arrival of the newsletter. The purpose is to verify the participant's latest
contact details and to review understanding of, and availability for,
remaining research procedures. As before, up to four attempts will be
made to reach the parent by telephone. Researchers carrying out
follow-up interviews will remain blind to the randomisation allocation
of the participants and will request that they do not reveal this until the
point at which process evaluation interviews are conducted. The ran-
domisation status of participants will be stated in a sealed envelope
which researchers will open after they have conducted the follow-up
assessment, and before they conduct the interview.
2.9.3. Interview with keyworkers
Parent participants will be informed verbally and in the PIS that we
may conduct a separate interview with their keyworker. Purposively
selected keyworkers will receive their own PIS and Consent Form prior
to taking part in this qualitative interview. Interviews will be conducted
by an unblinded researcher. Keyworkers will not be reimbursed for
their participation.
2.9.4. Strategies for promoting participant compliance, retention and
completing follow-up
Participants' attendance at scheduled sessions will be logged by HFP
therapists (intervention arm) and parent facilitators (control arm). The
following activities will support adherence to study procedures at ﬁrst
and second follow-up in both trial arms:
(i) All participants will receive a text message reminder about a
forthcoming ﬁrst or second follow-up assessment; messages will be
sent two weeks prior to the intended assessment date, mentioning
that a researcher will follow up in a telephone call to conﬁrm a
convenient time and location
(ii) If a participant cannot be reached by telephone after four con-
secutive attempts (2 calls and 2 text messages), s/he will be texted
and asked to opt in for any further contact
(iii) If contact is unsuccessful at the ﬁrst follow-up, renewed eﬀorts will
be made at the second follow-up unless a parent speciﬁcally opts
out of all further contact
(iv) All of the telephone calls, successful and unsuccessful, will be
documented
(v) A further reminder text message will be sent 24 h before a
scheduled assessment meeting
Each participant will receive a telephone call from a researcher to
check the participant's latest contact details and to review under-
standing of, and availability for, remaining research procedures. As
before, up to four attempts will be made to reach the parent by tele-
phone; details of these calls will be logged.
2.9.5. Data management
Identiﬁable data, such as participant names and addresses will be
removed from completed research measures, and an anonymous iden-
tiﬁcation number will be assigned to each participant to identify the
questionnaires and demographic information. Personal data (e.g. par-
ticipant names and contact details) will only be transferred electro-
nically using encrypted USB drives or secure NHS email servers.
Qualitative interviews will be recorded on encrypted devices (e.g.
iPhones or iPads), as per the requirement of the sponsor. Completed
recordings will be uploaded onto password-protected computers and
deleted from recording devices once transcribed. Eﬀorts will be made to
upload and transcribe recordings as soon as possible after interviews
have been completed. In order to preserve anonymity, participant
numbers will be assigned to each participant to identify the interview
transcript, and pseudonyms will be used in interview transcripts where
participants mention names, places or any other information that could
be used to identify them.
The Chief Investigator will act as custodian of the data in
accordance with the UK Data Protection Act and the terms of the
Sponsor and Funder. Personal contact details of participants will be
retained for the duration of the trial to enable follow-up. Other research
data generated by the study will be retained for 7 years to cover con-
tractual liability.
2.10. Analysis plan
2.10.1. Statistical methods
The statistical analysis for this pilot trial will be mainly descriptive
in nature, aiming to provide estimates of key trial parameters and to
inform power calculations for a future deﬁnitive trial. A description of
the sample will be presented using means and standard deviations for
continuous data, or medians and interquartile range if data are skewed.
Frequencies and proportions will be used to analyse categorical vari-
ables. Feasibility of trial procedures will be assessed using proportions
of predetermined parameters and their estimated 95% CIs. We will
analyse primary clinical outcomes using multi-level models [32] to
estimate the likely range of the treatment eﬀect (by assessing 95% CI)
at post-treatment and 6-month follow-up (with pre-randomization va-
lues as a covariate). Population variances for future power calculations
will be determined using the upper 80th percentile of conﬁdence in-
tervals around the estimated population variance, as recommended by
Browne [29].
2.10.2. Economic evaluation
Diﬀerences in mean total costs between experimental and control
groups will be compared using ordinary least squares regression ad-
justing for baseline costs and with bootstrapped conﬁdence intervals
generated due to the likely skewed regression residuals [33]. Costs will
be viewed alongside all outcomes (but not formally linked) in a cost-
consequences analysis. A cost-utility analysis will subsequently be
conducted by linking the cost data with QALYs. QALY gains will be
calculated using area under the curve methods, controlling for baseline
utility [34]. The point estimates of cost and QALYs will indicate whe-
ther the new health technology is dominant (resulting in better out-
comes at lower cost) or whether each extra QALY produced by the in-
tervention (or indeed usual care) is at an increased cost. Uncertainty
around cost-eﬀectiveness estimates will be addressed using cost-eﬀec-
tiveness planes (produced by generating 1000 cost-QALY combinations
using bootstrapping). This will allow us to determine the probability
that the intervention results in (i) lower costs and more QALYs, (ii)
lower costs and fewer QALYs, (iii) increased costs and fewer QALYs, or
(iv) increased costs and more QALYs than usual care. Cost-eﬀectiveness
results will be further interpreted using cost-eﬀectiveness acceptability
curves (CEACs) generated using the net beneﬁt approach where the
monetary value of an individual's QALY gain minus their service cost is
calculated [32]. A range of threshold QALY values will be used to in-
clude the £20–30,000 value used by National Institute of Health and
Care Excellence [35].
From this pilot evaluation, we will be able to generate indicative
cost-eﬀectiveness estimates. We do not propose to model beyond the
pilot study period but that will be desirable in a future study. However,
we will need to address the expected uncertainty around speciﬁc cost
variables in the analysis and this will inform future data collection
methods. In particular, we will explore the impact on the results of
varying the cost of the intervention, the cost of parental time and the
cost of lost school days.
2.10.3. Process evaluation
The primary aims of the process evaluation analysis are to assess the
acceptability of, and adherence to, recruitment procedures in UK NHS
and local authority services, and to investigate the impact of contextual
factors upon the implementation of HFP and the its outcomes.
Qualitative interview transcripts will be downloaded to NVivo, a
computer package for the management, classiﬁcation and analysis of
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text-based data. Thematic coding frameworks will be constructed to
allocate codes to emergent themes and issues within the data, facil-
itating their identiﬁcation and organisation. Transcripts will be in-
dependently coded by at least two researchers (including a service user
researcher) to enable discrepancies to be identiﬁed and consensus
reached about the interpretation and application of the coding frame-
work. Data that do not ﬁt the initial coding framework will lead to the
generation of new themes and framework revision. Data will then be
consistently classiﬁed, indexed and subject to thematic analysis using
the reﬁned coding framework. Validation will be undertaken with a
sample of participants. Qualitative themes will be triangulated with a
descriptive analysis of quantitative feasibility parameters related to
participant enrolment and intervention use.
2.11. Trial governance
2.11.1. Trial Steering Committee
The Chief Investigator will report to an independent Trial Steering
Committee (TSC) responsible for ensuring scientiﬁc integrity of the
trial. The TSC has been established since mid-2014 and has overseen a
pre-pilot feasibility study. The Chair is Prof. Peter Fonagy, Freud
Memorial Professor of Psychoanalysis at University College London.
Other independent members include senior clinicians and academics
with expertise in trials and/or families with complex interpersonal
needs. The TSC will meet every six months to monitor, review and
supervise research progress.
2.11.2. Data Monitoring and Ethics Committee
A Data Monitoring and Ethics Committee (DMEC) will monitor in-
terim safety and eﬃcacy data. The DMEC has been established in par-
allel with the TSC since mid-2014. The Chair is Prof. Philip Graham
(Emeritus professor of Child Psychiatry at the Institute of Child Health,
London). The TSC will liaise with the DMEC should safety, ethical or
eﬃcacy issues emerge, with implications for continuing, modifying or
stopping the trial.
2.11.3. Service user participation and involvement
Service user panels will be convened to inform the development of
the intervention manual and recruitment pathways. Service user re-
presentatives will be appointed to sit on the Trial Steering Committee
and to attend meetings of the Project Management Group. A service
user researcher will provide expert guidance on the interpretation of
the Process Evaluation ﬁndings.
2.12. Ethics, consent and permissions
2.12.1. Research ethics approval
Ethics approval was obtained from Health Research Authority South
East Coast - Brighton & Sussex Research Ethics Committee (reference:
16/LO/0199).
2.12.2. Consent and conﬁdentiality
2.12.2.1. Access to databases. The Chief Investigator (CD) will act as
custodian of the data in accordance with legislation and the theirs of the
research sponsor (King's College London) and funder (National Institute
for Health Research, UK).
2.12.3. Adverse events
The Chief Investigator will report any serious adverse event that is
both related to the research procedures and is unexpected to the
Research Ethics Committee that gave a favourable opinion of the re-
search. Researchers carrying out interviews and assessments with par-
ticipants will be instructed to report any adverse circumstances to the
Project Manager and Principal Investigator, no matter how minor the
circumstances might appear. Therapists engaged with participants will
be asked to impart information on potentially serious adverse events to
their supervisor and/or the Principal Investigator during weekly su-
pervision sessions. A standard form for reporting serious adverse events
will be circulated to all trial staﬀ.
3. Discussion
This study focuses on providing help for two marginalised and often
linked vulnerable populations 1) parents with clinically signiﬁcant
personality diﬃculties 2) their young children with emotional and be-
havioural problems. These parents and their children have very high
levels of unmet need and we currently lack robust evidence on the best
way to help them. HFP is the ﬁrst intervention of its kind designed to
help these groups and our study will test the feasibility of evaluating
HFP using a randomised design.
The primary aim of this study is to assess the feasibility of a full-
scale trial to deliver a psychoeducational parenting intervention for
families aﬀected by personality diﬃculties. The Helping Families
Programme intervention provides an important alternative to existing
group-based interventions for parents whose interpersonal problems
present barriers to intervention engagement and achievement of im-
proved outcomes. There is currently a signiﬁcant gap in evidence-based
services for these families, and this feasibility study will test whether a
trial of this intervention is possible. Positive feasibility ﬁndings for the
research and intervention methods and measures will provide a plat-
form for the planning and conduct of a subsequent full-scale trial.
The strengths of the protocol lie in its scope and methods of re-
cruitment. Parents who themselves have personality diﬃculties and
whose children have signiﬁcant mental health problems can be service
users in adult and child mental health services as well as clients of
social care services. Often the parental and child needs are under-re-
cognised and care tends to focus on the needs of the individual adult or
child. This protocol actively seeks to recruit from across services sectors
rather than restricting recruitment to speciﬁc service types. The re-
search team will need to engage and communicate with a wide range of
practitioners and service provision. The breadth of recruitment routes
means that parents located in a range of existing pathways will be given
the opportunity to participate in the trial. All parents meeting eligibility
criteria will receive support that is additional to the common forms of
usual care typically available. Once screened, individual participants
will have the chance of allocation to the HFP intervention, an intensive
16 session psychoeducation intervention. Parents randomised to the
control arm will receive a manualised one session parenting interven-
tion with a qualiﬁed therapist based on an existing evidence based
programme [16].
Recruitment through this protocol is intended to include parents
who have previously received formal assessment, diagnosis and treat-
ment for their complex interpersonal diﬃculties. It is also intended to
be open to parents who meet eligibility criteria but who have not re-
ceived previously received formal diagnosis and intervention. The latter
group of parents are more likely to be found in child mental health and
social care services, where diagnostic assessment of the adult parent is
not within the scope of services. The protocol uses eligibility criteria
based on the use of the SAPAS as a screening measure rather than
formal diagnosis of personality disorder. Earlier feasibility work that
informed the development of this protocol indicated that many poten-
tially eligible parents had not received formal diagnosis. In addition,
staﬀ and service user consultations expressed concerns about the ac-
ceptability of screening procedures for the study using diagnostic in-
struments such as the Development and Well-Being Assessment
(DAWBA) and the Structured Clinical Interview for DSM Disorders-II
(SCID) [36]. There are important ethical and personal implications of
using a research administration of instruments such as the SCID with
parents who have not previously sought diagnosis for complex inter-
personal diﬃculties.
Use of the SAPAS as a screening tool enables participation in the
trial of individuals who might otherwise have been excluded because
C. Day et al. Contemporary Clinical Trials Communications 8 (2017) 67–74
72
they have not previously sought a formal diagnosis for their inter-
personal diﬃculties. However, not including diagnosis as an eligibility
criteria has potential implications for the interpretation of the trial
results against studies which do use such inclusion criteria.
Further limitations to the protocol include the use of parent in-
formant self-report outcome measures which is reliant on parents' ac-
curate and reliable assessment of their own and their children's func-
tioning across a range of domains. The inclusion of third party
assessment measures would increase validity but are not feasible within
the funding available for this pilot study. Furthermore, consideration
needs to be given to the recognised variations and discrepancies be-
tween parent, child and other informant ratings of child outcomes.
Evidence suggests that there is an under-recognition of coexisting
parent and child mental health problems. Feasibility work underlined
the challenges underpinning this under-recognition, in which adult
mental health practitioners focussed on the care of their adult service
user, gave limited attention to the mental health of their children, and
potential parenting diﬃculties. Within child mental health services,
clinician assessment and intervention is focussed on the young person,
with limited attention to the interpersonal function of the adult parent
and the eﬀects on their parenting. These practice diﬀerences are likely
to aﬀect the ability of practitioners across referring services to identify
potentially eligible participants and conﬁdently involve the parents in
an open and informed discussion about participation. The research
team has developed proactive methods to support and train practi-
tioners from across service sectors to preliminary identify participants
and engage them in the study.
The trial aims to examine the feasibility of conducting a randomised
design to test a new intervention for families aﬀected by personality
diﬃculties, whose needs are typically under-served. Although the im-
pact of the active intervention are as yet unknown, parent participants
randomised to the Usual Care arm of the trial may be disappointed by
their allocation. Such disappointment may lead to participant with-
drawal or to further help-seeking outside of the parameters of the trial.
Any additional service utilisation will be recorded through the CSRI.
Participant retention and withdrawal reasons will be recorded as part of
the assessment of trial feasibility.
This is a new intervention for a highly vulnerable population of
parents and children where there are signiﬁcant deﬁcits in evidence
based interventions and clinical practice. This paper describes a re-
search protocol for a pilot randomised control trial for a new psy-
choeducational parenting intervention that will provide feasibility data
that will be used to inform the design and planning for a full-scale trial.
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